Central venous Access device SeCurement And Dressing Effectiveness: the CASCADE Trial

Not Applicable

Completed

• Conditions: Central venous access device failure prior to completion of therapy; Public Health - Health service research

• Registration Number: ACTRN12613001103752
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2444

Inclusion Criteria

1. Informed written consent
2. CVAD to be inserted for clinical care (includes peripherally inserted central catheters, percutaneous central catheters, tunnelled central catheters).

Exclusion Criteria

1. Current bloodstream infection
2. Non-English speaking patients without interpreter
3. CVADS inserted through diseased, burned or scarred skin
4. Current skin tear/'paper' skin at high risk of tear
5. Known allergy to any study product
6. Extremely diaphoretic patients

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CVAD failure:<br><br>Composite measure of any reason for unplanned CVAD removal, prior to the completion of therapy. This includes (i) Central Line-Associated Bloodstream Infection (CLABSI); (ii) local infection of skin or sutures: (iii) dislodgement: (iv) occlusion and (v) CVAD breakage.<br><br>The primary outcome of device failure is an objective measure, assigned by clinical staff (not research staff or investigators). This is routine clinical practice. Research staff will collect the primary endpoint from the medical records with additional information obtained from the clinical staff/patients if required.<br>[At the time of CVAD removal.]